Participants say GartnerGroup spin-off from IMS on schedule’
IMS HEALTH (Westport, CT) and GartnerGroup (Stamford, CT) said a proxy statement for the previously announced spin-off of Gartner from IMS has been filed with the Securities and Exchange Commission and that the spin-off is on schedule. A special shareholders meeting will be held after the proxy statement is approved by the SEC and distributed to GartnerGroup shareholders, the companies said.
Before the spin-off, 40.7 million of the 47.6 million GartnerGroup shares owned by IMS will be exchanged for new Class B common stock of GartnerGroup as part of a GartnerGroup recapitalization. Holders of the Class B common stock will be entitled to elect at least 80% of GartnerGroup’s board of directors, but will otherwise be essentially identical to existing Class A common stock. All Class B shares will be distributed to IMS Health shareholders in a tax-free distribution upon approval of the spin-off.
The boards of both companies have agreed to amend the terms of the transaction to provide for an increased share repurchase by GartnerGroup, which has committed to repurchase 20% of its outstanding shares the maximum amount allowed by IRS rules. IMS Health is an international provider of information solutions to the pharmaceutical and healthcare industries. GartnerGroup provides a wide range of IT advisory services, measurement, research, decision support, analysis and consulting.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content